USPTO serial 77497882
GENEART - THE PROTEIN OF YOUR CHOICE
Reviewed by CopyMark Law Group
Reg. 3668354Status 710
- Filing date
- Status date
- Registration date
- Aug 18, 2009
- Examiner
- MITTLER, ROBIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GENEART - THE PROTEIN OF YOUR CHOICE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Regensburg, DE
Regensburg, DE
Regensburg, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Phil Makrogiannis
Phil Makrogiannis Life Technologies Corporation5791 Van Allen WayCarlsbad, CA 92008UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes, namely, for laboratory analysis in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; chemical preparations for scientific purposes in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; bacteria preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; microorganism cultures for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biological materials for clinical, scientific, research and medical laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical, scientific, research and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof; enzymes and enzyme preparations for use in the field of food manufacture, waste treatment, fermentation, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biological materials for medical diagnostic laboratory use, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof; deoxyribonucleic acid, especially deoxyribonucleic acid comprising 80 to 150 base pairs for scientific and research purposes; and genes, namely, genes comprising 80 to 150 base pairs for scientific and research purposes | SECTION 8 - CANCELLED | — |
| 005 | Medicines for human-medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, Alzheimer's and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; bacteriological preparations for medical and veterinary purposes for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, Vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; germicides for medical and laboratory equipment and for institutional and domestic uses; vermicides for medical and laboratory equipment and for institutional, domestic, and residential uses; fungicides for medical and laboratory equipment and for institutional and domestic uses; deoxyribonucleic acid, namely, deoxyribonucleic acid comprising 80 to 150 base pairs for diagnostic medical purposes; and genes, namely, genes comprising 80 to 150 base pairs for medical diagnostic purposes | SECTION 8 - CANCELLED | — |
| 007 | Filling machines; machine parts, namely, machine housings; membranes specially designed for electric pumps; mixers; pumps, namely, electric pumps; regulators being parts of machines; industrial robots; separators, namely, centrifugal separators | SECTION 8 - CANCELLED | — |
| 009 | Scientific and laboratory equipment, namely, automatic machines for the synthesis of deoxyribonucleinic acids; robot machines for laboratory purposes; computer terminals; computer programs for use as tools for design and synthesis of deoxyribonucleic acids, genes and proteins; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations and diagnostic preparations; computer operating programs; computer peripheral devices; computer keyboards; blank magnetic data carriers; blank optical disks; data processing apparatus, namely, data processors; computer memories; blank floppy computer disks; blank hard drives for computers; printers for use with computers; computer interfaces; laptop computers; data processors, namely, readers and scanners; computer mouse; microprocessors in the nature of semiconductors; computer modems; computer monitors; computer hardware; and notebook computers | SECTION 8 - CANCELLED | — |
| 042 | Computer services, namely, updating of computer software for others, consulting in the field of biotechnology, designing computer software for others, maintenance of computer software for others, rental of computer software, computer programming for others, leasing of computers, and reconstruction of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, genetic engineering, and machine engineering; medical laboratory services for others in the fields of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics research, engineering and machine engineering; consultation in the field of pharmacology; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection; technical project planning and technology consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics research, engineering, and machine engineering; and quality control for others | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Geneart AG
- Other trademarks owned by Geneart AG
- Other trademarks owned by Geneart AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named GENEART - THE PROTEIN OF YOUR CHOICE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 25, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 23, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 21, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 21, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 2, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 1, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 18, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 2, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 27, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 27, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 27, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 27, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 27, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 14, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 14, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 14, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 14, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 24, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 23, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 23, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2008 | NWAP | NEW APPLICATION ENTERED | — |